United Bank (Virginia)’s Trevi Therapeutics TRVI Stock Holding History

United Bank (Virginia)’s Portfolio TRVI Stock Details TRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$582K	Hold	31,200	–	–	0.07%	97
2026 Q1	$372K	Hold	31,200	–	–	0.05%	105
2025 Q4	$391K	Hold	31,200	–	–	0.05%	99
2025 Q3	$285K	Hold	31,200	–	–	0.03%	110
2025 Q2	$171K	Hold	31,200	–	–	0.02%	135
2025 Q1	$196K	Hold	31,200	–	–	0.03%	133
2024 Q4	$129K	Hold	31,200	–	–	0.02%	129
2024 Q3	$104K	Hold	31,200	–	–	0.01%	135
2024 Q2	$93K	Buy	31,200 +2,750	+10%	+$7.64K	0.01%	135
2024 Q1	$98.2K	Hold	28,450	–	–	0.01%	140
2023 Q4	$38.1K	Hold	28,450	–	–	﹤0.01%	141
2023 Q3	$62K	Hold	28,450	–	–	0.01%	140
2023 Q2	$68K	Hold	28,450	–	–	0.01%	148
2023 Q1	$52.6K	Hold	28,450	–	–	0.01%	154
2022 Q4	$54.9K	Hold	28,450	–	–	0.01%	153
2022 Q3	$44K	Hold	28,450	–	–	0.01%	153
2022 Q2	$80K	Buy	28,450 +1,750	+7%	+$4.3K	0.01%	144
2022 Q1	$59K	Buy	+26,700	New	+$27.7K	0.01%	157

Other funds holding TRVI

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

United Bank (Virginia)'s TRVI Position: Q2 2026 in Review

United Bank (Virginia) held its Trevi Therapeutics (TRVI) position steady in Q2 2026 at 31,200 shares worth $582K. The position accounts for 0.07% of the portfolio, ranked #97.

United Bank (Virginia) first reported a position in TRVI in Q1 2022 and has held it in 18 quarters since. 218 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

United Bank (Virginia) held 31,200 shares of Trevi Therapeutics worth $582K as of Q2 2026.
United Bank (Virginia) left its Trevi Therapeutics share count unchanged in Q2 2026.
Trevi Therapeutics made up 0.07% of United Bank (Virginia)'s portfolio in Q2 2026, its #97 holding.
United Bank (Virginia) first reported a position in Trevi Therapeutics in Q1 2022 and has held it in 18 quarters since.
218 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on United Bank (Virginia)'s 13F filing for Q2 2026, filed 30 Jul 2026.